Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.76 USD | -1.36% | -5.24% | -18.53% |
06:31pm | Bristol-Myers Squibb Unveils Positive Data for KarXT in Schizophrenia Treatment | MT |
May. 22 | Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.53% | 85.83B | |
+39.68% | 723B | |
+34.28% | 595B | |
-4.02% | 369B | |
+20.35% | 332B | |
+2.83% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.17% | 168B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Deutsche Bank Adjusts Price Target on Bristol-Myers Squibb to $53 From $55, Keeps Hold Rating